FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NYSE:GNW

Sort
E.g., 2013-05-20
E.g., 2013-05-20
Enter a comma separated list of user names.

Newcastle Investment Corp. (NYSE:NCT) announced that it has completed the sale of 25,875,000 shares of its common stock at a price of $4.55 per share. The gross proceeds of the sale were approximately $117.7 million, including proceeds from the sale of 3,375,000 shares pursuant to the exercise in full of the underwriters' option to purchase additional shares of common stock.

STMicroelectronics N.V., (NYSE:STM) has introduced a new memory with a unique ultra-fast recording feature for storing important data during unexpected events. Its uses will include recovering system data when a sudden power failure occurs, and 'black-box' recorders that help identify the causes of equipment failures or accidents.

Brookfield Properties Corporation (NYSE:BPO) announced that net income attributable to common shareholders for the year ended December 31, 2010 was $1,552 million or $2.73 per diluted share, compared with a loss of $220 million or ($0.52) per diluted share in 2009.

GreenHouse Holdings, Inc. (OTCQB:GRHU), a San Diego, California based integrated energy solutions provider and developer of eco-friendly infrastructure, announced the signing of a Letter of Intent to acquire Control Engineering, Inc (CEI).

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

AirTran Holdings Inc. (NYSE:AAI) reported on November 2, 2010 traffic for the month of October.

Genworth Financial Inc. (NYSE:GNW) CFO Patrick B. Kelleher has been named chief executive of the investment company’s retirement and protection business, launching the company’s search for a new head of finance.

Crown Equity Holdings Inc. (OTCBB:CRWE) announced recently that it has launched its crwenewswire.fr website to provide news in France's native language. Crown Equity Holdings Inc. had previously launched its German website crwenewswire.de and is launching its Canadian website crwenewswire.ca, soon.

Proteonomix, Inc. (PROT.OB) – Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products.

ADVERTISE WITH US